Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - ALNYLAM PHARMACEUTICALS, INC.Financial_Report.xls
EX-31.1 - EX-31.1 - ALNYLAM PHARMACEUTICALS, INC.d791772dex311.htm
EX-32.2 - EX-32.2 - ALNYLAM PHARMACEUTICALS, INC.d791772dex322.htm
EX-31.2 - EX-31.2 - ALNYLAM PHARMACEUTICALS, INC.d791772dex312.htm
EX-32.1 - EX-32.1 - ALNYLAM PHARMACEUTICALS, INC.d791772dex321.htm
EX-10.1 - EX-10.1 - ALNYLAM PHARMACEUTICALS, INC.d791772dex101.htm
10-Q - 10-Q - ALNYLAM PHARMACEUTICALS, INC.d791772d10q.htm

Exhibit 12

STATEMENT REGARDING COMPUTATION OF CONSOLIDATED RATIOS OF EARNINGS/DEFICIENCIES TO FIXED CHARGES

(dollars in thousands)

 

                Fiscal Year Ended December 31,  
    Nine Months Ended
September 30, 2014
    Three Months Ended
September 30, 2014
    2013     2012     2011     2010     2009  

Earnings (loss):

             

Pre-tax loss from continuing operations before adjustment for loss from equity investee

  $ (357,124   $ (43,922   $ (91,920   $ (112,064   $ (54,144   $ (35,362   $ (42,098

add: Fixed charges (see below)

    1,251       517       678       1,188       1,207       1,207       712   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Pre-tax loss from continuing operations before adjustment for income/loss from equity investees plus fixed charges

  $ (355,873   $ (43,405   $ (91,242   $ (110,876   $ (52,937   $ (34,155   $ (41,386

Fixed charges:

             

Interest expense on portion of rent expense representative of interest

  $ 1,251      $ 517      $ 678     $ 1,188     $ 1,207      $ 1,207      $ 712   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total fixed charges

  $ 1,251     $ 517     $ 678     $ 1,188     $ 1,207     $ 1,207     $ 712   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratio of earnings to fixed charges

    —         —         —         —         —         —         —    
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Deficiency of earnings available to cover fixed charges

  $ (357,124 )   $ (43,922 )   $ (91,920 )   $ (112,064 )   $ (54,144 )   $ (35,362 )   $ (42,098